These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 38343627)

  • 1. Improving phage therapy by evasion of phage resistance mechanisms.
    Bleriot I; Pacios O; Blasco L; Fernández-García L; López M; Ortiz-Cartagena C; Barrio-Pujante A; García-Contreras R; Pirnay JP; Wood TK; Tomás M
    JAC Antimicrob Resist; 2024 Feb; 6(1):dlae017. PubMed ID: 38343627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conquering CRISPR: how phages overcome bacterial adaptive immunity.
    Malone LM; Birkholz N; Fineran PC
    Curr Opin Biotechnol; 2021 Apr; 68():30-36. PubMed ID: 33113496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
    Rollie C; Chevallereau A; Watson BNJ; Chyou TY; Fradet O; McLeod I; Fineran PC; Brown CM; Gandon S; Westra ER
    Nature; 2020 Feb; 578(7793):149-153. PubMed ID: 31969710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria.
    Hasan M; Ahn J
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance is not futile: bacterial 'innate' and CRISPR-Cas 'adaptive' immune systems.
    Fineran PC
    Microbiology (Reading); 2019 Aug; 165(8):834-841. PubMed ID: 30958259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveil the Secret of the Bacteria and Phage Arms Race.
    Wang Y; Fan H; Tong Y
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?
    Ceballos-Garzon A; Muñoz AB; Plata JD; Sanchez-Quitian ZA; Ramos-Vivas J
    Pathog Dis; 2022 Oct; 80(1):. PubMed ID: 36255384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm control with natural and genetically-modified phages.
    Motlagh AM; Bhattacharjee AS; Goel R
    World J Microbiol Biotechnol; 2016 Apr; 32(4):67. PubMed ID: 26931607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria.
    Liu H; Li H; Liang Y; Du X; Yang C; Yang L; Xie J; Zhao R; Tong Y; Qiu S; Song H
    Theranostics; 2020; 10(14):6310-6321. PubMed ID: 32483454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage "delay" towards enhancing bacterial escape from biofilms: a more comprehensive way of viewing resistance to bacteriophages.
    Abedon ST
    AIMS Microbiol; 2017; 3(2):186-226. PubMed ID: 31294157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage and phage cocktails formulations.
    Mani I
    Prog Mol Biol Transl Sci; 2023; 200():159-169. PubMed ID: 37739554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
    Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
    Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy.
    Azam AH; Tanji Y
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2121-2131. PubMed ID: 30680434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas phage defense systems and prophages in Candidatus Accumulibacter.
    Deng X; Yuan J; Chen L; Chen H; Wei C; Nielsen PH; Wuertz S; Qiu G
    Water Res; 2023 May; 235():119906. PubMed ID: 37004306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arms race in a cell: genomic, transcriptomic, and proteomic insights into intracellular phage-bacteria interplay in deep-sea snail holobionts.
    Zhou K; Xu Y; Zhang R; Qian PY
    Microbiome; 2021 Sep; 9(1):182. PubMed ID: 34479645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
    Shariati A; Noei M; Chegini Z
    J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.